Plasma proteome correlations with liver stiffness in pediatric cholestasis implicate epithelial to mesenchymal

Benjamin L Shneider1, Rupa S Kanchi2, Sandra L Grimm3

  • 1Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.

Hepatology Communications
|September 29, 2025
PubMed

Insights

The plasma proteome correlates with liver stiffness in pediatric liver diseases like biliary atresia (BA), alpha-1 antitrypsin deficiency (A1AT), and Alagille syndrome (ALGS), offering new biomarker opportunities.

Area of Science:

  • Hepatology
  • Proteomics
  • Pediatric Gastroenterology

Background:

  • Pediatric cholestatic liver diseases, including biliary atresia (BA), alpha-1 antitrypsin deficiency (A1AT), and Alagille syndrome (ALGS), are characterized by rapid fibrosis.
  • Liver stiffness measurements (LSM) are crucial for assessing disease progression.

Purpose of the Study:

  • To investigate the relationship between plasma proteome and liver stiffness measurements (LSM) in children with BA, A1AT, and ALGS.
  • To identify potential biomarkers for pediatric cholestatic liver diseases.

Main Methods:

  • Utilized slow off-rate modified aptamer scanning to profile over 7000 proteins in plasma from 187 children (BA, A1AT, ALGS) and 17 controls.
  • Correlated plasma proteomic data with liver stiffness measurements (LSM) using Weighted Correlation Network Analysis and machine learning models.

Main Results:

  • Identified a significant number of LSM-correlated proteins, with distinct proteomes in ALGS compared to BA and A1AT.
  • Developed machine learning models that accurately predict LSM (median R2=0.62 for BA) and transplant time in BA.
  • Single-cell transcriptomics indicated macrophage, mesenchymal, mesothelial, and endothelial cells as origins for informative proteins, with enrichment of the epithelial-to-mesenchymal transition pathway.

Conclusions:

  • The plasma proteome shows disease-specific correlations with LSM in BA, A1AT, and ALGS.
  • These findings highlight the potential for novel biomarker discovery and underscore the role of epithelial-to-mesenchymal transition in pediatric cholestasis.
Abstract